Singular Health Group logo

Singular Health Group(ASX) SHG

Market CapA$53.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-55%
5 Year-15%
1 Year-41%
1 Month-15%
A$0.17
-2.94%
-0.00Today
Singular Health Group last closing stock price
MetricPriceDate
Last closeAUD 0.172026-10-09
Singular Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.81%AUD 0.192026-10-02
1 month-15.38%AUD 0.202026-09-09
3 month-21.43%AUD 0.212026-07-10
Year to date-35.29%AUD 0.262025-12-31
1 year-41.07%AUD 0.282025-10-09
3 year+323.08%AUD 0.042023-10-10
5 year-15.38%AUD 0.202021-10-08
Since inception-55.26%AUD 0.382021-02-12

Singular Health Group Financials at a Glance

Market Cap

A$53.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$1.99M

Net Income (TTM)

-A$12.72M

EPS (TTM)

-A$0.02

P/E Ratio

-8.13

Dividend

A$0.00

Beta (Volatility)

-0.22 (Low)

Price

A$0.17

Volume

173,894

Open

A$0.17

Previous Close

A$0.17

Daily Range

A$0.17 - A$0.17

52-Week Range

A$0.17 - A$0.35

Estimated Earnings Date

Mar 3, 2027

SHG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Singular Health Group

Singular Health Group Ltd is a medical technology company focused on developing and commercializing a volumetric rendering platform (VRP). This innovative platform enables three-dimensional and virtual reality presentations of anatomical data derived from standard radiological imaging.

Products and Services
  • 3Dicom Viewer for engaging with 2D medical images
  • 3DicomVSP for comprehensive surgical planning
  • Health Academy, a multi-language educational platform
Growth Outlook
  • Expansion into virtual reality applications in healthcare is gaining traction
  • Increased demand for 3D imaging solutions in medical education and training
  • Strategic partnerships may enhance market reach and product offerings
Financial Highlights
  • Recent quarterly revenue of 948,936 AUD shows growth potential
  • Cash and short-term investments total 10,062,017 AUD, providing liquidity
  • Current ratio of 18.19 indicates strong short-term financial health
Singular Health Group Ltd operates in the healthcare information services sector, leveraging advanced technology to improve medical imaging and education. The company's flagship products, including the 3Dicom Viewer and 3DicomVSP, are designed to enhance the user experience in medical imaging and surgical planning. The Health Academy platform further supports educational initiatives, making it a versatile player in the medical technology landscape. The growth outlook for Singular Health is promising, driven by the increasing adoption of virtual reality in healthcare and the rising need for advanced imaging solutions. The company is well-positioned to capitalize on these trends, particularly through potential strategic partnerships that could broaden its market presence. Financially, the company has demonstrated resilience, with a recent quarterly revenue of 948,936 AUD, reflecting its ability to generate income despite challenges. The strong cash position, with over 10 million AUD in cash and short-term investments, provides a solid foundation for future growth initiatives. Additionally, a current ratio of 18.19 indicates robust short-term financial health, suggesting that the company can meet its short-term obligations comfortably. Overall, Singular Health Group Ltd represents an intriguing opportunity within the medical technology sector, with innovative products and a favorable growth trajectory.
AI Generated • Sep 28, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Denning Chong

Website

www.singular.health

Headquarters

Leederville, WA 6007, AU

SHG Financials

Key Financial Metrics (TTM)

Gross Margin

-284.10%

Operating Margin

-472.40%

Net Income Margin

-443.94%

Return on Equity

-57.06%

Return on Capital

-63.63%

Return on Assets

-56.43%

Earnings Yield

-12.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$53.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

326.09M

Volume

173.89K

Avg. Volume

255.86K

Financials (TTM)

Gross Profit

-A$4.14M

Operating Income

-A$12.95M

EBITDA

-A$12.93M

Operating Cash Flow

-A$7.64M

Capital Expenditure

-A$172.99K

Free Cash Flow

-A$7.82M

Cash & ST Invst.

A$10.06M

Total Debt

A$109.96K

Singular Health Group Performance Analysis

Singular Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 28,122-48.0%
20242024-06-30AUD 90,825223.0%
20252025-06-30AUD 203,069123.6%
20262026-06-30AUD 1,428,231603.3%
Singular Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-30-90.6%
Q42025-06-30539.8%
Q22025-12-31-0.6%
Q42026-06-3098.0%
Singular Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.05-15.8%
20242024-06-30AUD -0.03-37.1%
20252025-06-30AUD -0.03-12.0%
20262026-06-30AUD -0.02-25.1%
Singular Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-30-5.3%
Q42025-06-30-15.0%
Q22025-12-3130.4%
Q42026-06-30-11.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$948.94K

+18.2%

Gross Profit

-A$1.86M

-413.7%

Gross Margin

-1.96%

N/A

Market Cap

A$53.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$6.73M

N/A

Employees

8

N/A

Net Income

-A$3.37M

+11.0%

EBITDA

-A$3.03M

-85.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$10.06M

+592.3%

Total Debt

A$109.96K

-49.7%

Accounts Receivable

A$859.36K

+1271.8%

Inventory

A$0.00

N/A

Long Term Debt

A$93.87K

N/A

Short Term Debt

A$16.10K

-92.6%

Return on Assets

-56.43%

N/A

Return on Invested Capital

-63.47%

N/A

Free Cash Flow

-A$2.22M

-10.7%

Operating Cash Flow

-A$2.19M

-9.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATX.AXAmplia Therapeutics Limited
A$0.11+0.00%
M7T.AXMach7 Technologies Limited
A$0.22-2.27%
CYC.AXCyclopharm Limited
A$0.46-3.16%
MX1.AXMicro-X Limited
A$0.06+18.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.14-9.97%
VEEAVeea
$6.19+59.95%
WFFWf
$4.03+96.54%
SPCXSpace Exploration Technologies
$162.08+0.94%

Questions About SHG

What is the current price of Singular Health Group?

Singular Health Group is trading at A$0.17 per share.

What is the 52-week range for Singular Health Group?

Over the past 52 weeks, Singular Health Group has traded between A$0.17 and A$0.35.

How much debt does Singular Health Group have?

As of the most recent reporting period, Singular Health Group reported total debt of A$109.96K.

How much cash does Singular Health Group have on hand?

Singular Health Group reported A$2.36M in cash and cash equivalents in its most recent financial results.

What is Singular Health Group’s dividend yield?

Singular Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services